Abstract
Cytomegalovirus continues to be an important pathogen in a variety of patient groups especially the neonate and the transplant recipient, and has implicated in a range of pathologies including inflammatory disease and in contributing to early death in ageing populations. This review will focus on advances in understanding the virus-host interaction and options for the new therapeutic control measures.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Antiviral Agents / therapeutic use
-
CD4-Positive T-Lymphocytes / physiology
-
CD8-Positive T-Lymphocytes / physiology
-
Cytomegalovirus / immunology
-
Cytomegalovirus / pathogenicity*
-
Cytomegalovirus Infections / prevention & control
-
Cytomegalovirus Infections / virology*
-
Cytomegalovirus Vaccines
-
Humans
-
Immunocompromised Host
-
Viral Load
Substances
-
Antiviral Agents
-
Cytomegalovirus Vaccines